IL304537A - מערכות להשהייה בקיבה בנתינת ריספרידון - Google Patents
מערכות להשהייה בקיבה בנתינת ריספרידוןInfo
- Publication number
- IL304537A IL304537A IL304537A IL30453723A IL304537A IL 304537 A IL304537 A IL 304537A IL 304537 A IL304537 A IL 304537A IL 30453723 A IL30453723 A IL 30453723A IL 304537 A IL304537 A IL 304537A
- Authority
- IL
- Israel
- Prior art keywords
- risperidone
- administration
- gastric residence
- residence systems
- systems
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title 1
- 229960001534 risperidone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139299P | 2021-01-19 | 2021-01-19 | |
| PCT/US2022/013027 WO2022159529A1 (en) | 2021-01-19 | 2022-01-19 | Gastric residence systems for administration of risperidone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL304537A true IL304537A (he) | 2023-09-01 |
Family
ID=87849812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL304537A IL304537A (he) | 2021-01-19 | 2023-07-17 | מערכות להשהייה בקיבה בנתינת ריספרידון |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL304537A (he) |
-
2023
- 2023-07-17 IL IL304537A patent/IL304537A/he unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292849A (he) | מערכת להשהייה בקיבה למתן חומרים פעילים | |
| IL291674A (he) | חברור של מערכות למתן תרופות | |
| EP4281049A4 (en) | GASTRIC RESIDENCE SYSTEMS FOR RISPERIDONE DELIVERY | |
| IL286518A (he) | כמוסות וציפויי כמוסות לצורות מינון לשהייה בקיבה | |
| IL275639A (he) | פורמולציה למתן rna | |
| WO2014204894A3 (en) | Vial transfer and injection apparatus and method | |
| IL280883A (he) | מערכות להעברה למעיים של חומרים תרופתיים | |
| IL288550A (he) | הרכבים רוקחיים למעכבי fcrn למתן תת-עורי | |
| IL269256A (he) | מערכת לאבחון אחר ניתוח או התאמת תרופה אנטי סרטנית בחולי סרטן מעי בשלב מתקדם | |
| IL286510A (he) | ציפויים לצורות מינון לשהייה בקיבה | |
| AU2018297348A1 (en) | Compositions for parenteral administration of therapeutic agents | |
| IL268127A (he) | תכשירים המכילים אדראוון למתן אוראלי או גסטרי ושימוש בהם לטיפול | |
| EP3941445A4 (en) | CAPSULES AND CAPSULE COATINGS FOR GASOLINE DOSAGE FORMS | |
| IL291603A (he) | צבירה מרחוק של נתונים עבור מכשירים למתן תרופות | |
| IL316048A (he) | יישומים טיפוליים של מערכות crispr מסוג v | |
| IL309664A (he) | מתן של נוגדנים אנטי- hpa-1a | |
| HK40104184A (en) | Gastric residence systems for administration of risperidone | |
| ZA202202931B (en) | System and method for infusion of drugs | |
| IL290421A (he) | מערכת הובלת תרופות להעברת חומרים אנטי ויראליים | |
| HK40080659A (en) | Gastric residence systems for administration of active agents | |
| GB202307942D0 (en) | Computer system for managing dosage timing of tacrolimus | |
| HK40004386A (en) | Gastric residence systems for sustained delivery of adamantane-class drugs | |
| HK40075570A (en) | Interconnection of drug administration systems | |
| CA3294216A1 (en) | Manufacturing methods for gastric residence systems | |
| HK40066496A (en) | Capsules and capsule coatings for gastric residence dosage forms |